目次

Executive Summary
Market overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product
Market segments
Comparison by Product
Conventional vaccines - Market size and forecast 2020-2025
Emergency vaccines - Market size and forecast 2020-2025
Market opportunity by Product

Geographic Landscape
Geographic segmentation
Geographic comparison
Asia - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
North America - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Biogenesis Bago SA
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Indian Immunologicals Ltd.
Inovio Pharmaceuticals Inc.
Merck & Co. Inc.
SEPPIC SA
VECOL SA
VETAL Animal Health Products Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Product - Market share 2020-2025 (%)
22: Comparison by Product
23: Conventional vaccines - Market size and forecast 2020-2025 ($ million)
24: Conventional vaccines - Year-over-year growth 2020-2025 (%)
25: Emergency vaccines - Market size and forecast 2020-2025 ($ million)
26: Emergency vaccines - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Product
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: Asia - Market size and forecast 2020-2025 ($ million)
32: Asia - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: North America - Market size and forecast 2020-2025 ($ million)
36: North America - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Biogenesis Bago SA - Overview
48: Biogenesis Bago SA - Product and service
49: Biogenesis Bago SA - Key offerings
50: Biogenesis Bago SA - Key customers
51: Biogenesis Bago SA - Segment focus
52: Boehringer Ingelheim International GmbH - Overview
53: Boehringer Ingelheim International GmbH - Business segments
54: Boehringer Ingelheim International GmbH - Key offerings
55: Boehringer Ingelheim International GmbH - Key customers
56: Boehringer Ingelheim International GmbH - Segment focus
57: Ceva Sante Animale - Overview
58: Ceva Sante Animale - Product and service
59: Ceva Sante Animale - Key offerings
60: Ceva Sante Animale - Key customers
61: Ceva Sante Animale - Segment focus
62: Indian Immunologicals Ltd. - Overview
63: Indian Immunologicals Ltd. - Product and service
64: Indian Immunologicals Ltd. - Key offerings
65: Indian Immunologicals Ltd. - Key customers
66: Indian Immunologicals Ltd. - Segment focus
67: Inovio Pharmaceuticals Inc. - Overview
68: Inovio Pharmaceuticals Inc. - Product and service
69: Inovio Pharmaceuticals Inc. - Key offerings
70: Inovio Pharmaceuticals Inc. - Key customers
71: Inovio Pharmaceuticals Inc. - Segment focus
72: Merck & Co. Inc. - Overview
73: Merck & Co. Inc. - Business segments
74: Merck & Co. Inc. - Key offerings
75: Merck & Co. Inc. - Key customers
76: Merck & Co. Inc. - Segment focus
77: SEPPIC SA - Overview
78: SEPPIC SA - Product and service
79: SEPPIC SA - Key offerings
80: SEPPIC SA - Key customers
81: SEPPIC SA - Segment focus
82: VECOL SA - Overview
83: VECOL SA - Product and service
84: VECOL SA - Key offerings
85: VECOL SA - Key customers
86: VECOL SA - Segment focus
87: VETAL Animal Health Products Inc. - Overview
88: VETAL Animal Health Products Inc. - Product and service
89: VETAL Animal Health Products Inc. - Key offerings
90: VETAL Animal Health Products Inc. - Key customers
91: VETAL Animal Health Products Inc. - Segment focus
92: Currency conversion rates for US$
93: Research Methodology
94: Validation techniques employed for market sizing
95: Information sources
96: List of abbreviations